Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Moderna Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One increased by 3.1% to $3.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.2%, from $4.35B to $3.30B. Over 5 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One shows an upward trend with a 10.1% CAGR.
Analysis
How to read this metric
Higher values indicate a larger portion of the portfolio is liquid and available for reinvestment or cash needs in the short term.
Detailed definition
This represents the amortized cost of debt securities in the available-for-sale portfolio that are scheduled to mature w...
Peer comparison
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_with_72951fHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $3.36B | $3.88B | $5.09B | $5.08B | $5.42B | $6.79B | $5.58B | $4.75B | $4.72B | $5.75B | $6.54B | $6.07B | $5.24B | $5.11B | $4.35B | $3.85B | $3.37B | $3.20B | $3.30B |
| QoQ Change | — | +40.7% | +15.7% | +31.2% | -0.3% | +6.7% | +25.4% | -17.9% | -14.8% | -0.7% | +21.8% | +13.6% | -7.2% | -13.6% | -2.6% | -14.8% | -11.5% | -12.5% | -5.1% | +3.1% |
| YoY Change | — | — | — | — | +112.9% | +61.4% | +75.0% | +9.4% | -6.5% | -12.9% | -15.3% | +17.2% | +27.7% | +11.0% | -11.2% | -33.4% | -36.5% | -35.7% | -37.3% | -24.2% |
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One at Other Companies
Frequently Asked Questions
- What is Moderna's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Moderna (MRNA) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one of $3.30B in Q1 2026.
- How has Moderna's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one changed year-over-year?
- Moderna's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one decreased by 24.2% year-over-year, from $4.35B to $3.30B.
- What is the long-term trend for Moderna's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one?
- Over 5 years (2020 to 2025), Moderna's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one has grown at a 10.1% compound annual growth rate (CAGR), from $1.98B to $3.20B.
- What does debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, year one mean?
- The book value of debt investments that will reach their maturity date within the next twelve months.